Candel Therapeutics Inc.

NASDAQ: CADL · Real-Time Price · USD
6.05
0.01 (0.17%)
At close: Aug 15, 2025, 3:59 PM
6.10
0.74%
After-hours: Aug 15, 2025, 07:51 PM EDT

Candel Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-55.18M -37.94M -18.79M -36.12M
Depreciation & Amortization
990K 960K 778K 232K
Stock-Based Compensation
5.31M 3.09M 2.31M 2.96M
Other Working Capital
531K -570K 1.28M -1.54M
Other Non-Cash Items
21.51M 169K -15.78M 76K
Deferred Income Tax
n/a n/a n/a 11.51M
Change in Working Capital
346K -525K 71K -876K
Operating Cash Flow
-27.02M -34.24M -31.42M -22.22M
Capital Expenditures
-16K -457K -1.3M -1.83M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 177K n/a n/a
Investing Cash Flow
-16K -280K -1.3M -1.83M
Debt Repayment
-9.17M n/a 19.91M n/a
Common Stock Repurchased
n/a -121K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.69M -121K 64K 465K
Financial Cash Flow
94.28M -121K 19.97M 71.8M
Net Cash Flow
67.24M -34.65M -12.74M 47.75M
Free Cash Flow
-27.04M -34.7M -32.72M -24.05M